The Greater Cannabis Company, Inc. (GCAN)

Price & Market Data

Price: $0.20

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $189,081

Daily Volume: 0

Performance Metrics

1 Week: 9.95%

1 Month: 13.76%

3 Months: 33.40%

6 Months: 122.3%

1 Year: -66.65%

YTD: 1.96%

About The Greater Cannabis Company, Inc. (GCAN)

Your daily market report for The Greater Cannabis Company, Inc. (GCAN). Price: 0.20, daily change: $0.00 / 0.00%. Market cap: 189,081. Full performance analysis from YTD to 52-week.

Company Details

Employees: 1

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.

Selected stocks

Providence Gold Mines Inc. (PRRVF)

Family Office of America Inc. (FOFA)

Aurubis Ag (AIAGY)

Proximus Group (BGAOF)

Franklin Mining, Inc. (FMNJ)